Blackhawk Network Holdings, Inc. (NASDAQ:HAWK) shares moved up 0.29% in last trading session and ended the day at $44.72. HAWK Gross Margin is 24.80% and its has a return on assets of 2.50%. Blackhawk Network Holdings, Inc. (NASDAQ:HAWK) quarterly performance is 0.77%.
On 27 October, Blackhawk Network Holdings, Inc. (NASDAQ:HAWK) announced its partnership with Samsung Pay, which will allow the integration of gift cards into the Samsung Pay mobile payment solution. Samsung Pay gives users a simple and convenient way to make payments through their phones almost anywhere you can swipe or tap your card. Blackhawk Network is a pioneer of prepaid gift cards, payments tools and rewards delivered via a robust and convenient network
Zogenix, Inc. (NASDAQ:ZGNX) ended the last trading day at $11.75. Company weekly volatility is calculated as 5.74% and price to cash ratio as 2.61. Zogenix, Inc. (NASDAQ:ZGNX) showed a weekly performance of -0.93%.
Zogenix, Inc. (NASDAQ:ZGNX), announced that it will report its financial results for the third quarter ended September 30, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, November 9, 2015, at 4:30pm Eastern Time.
On 05 November, Birner Dental Management Services Inc. (NASDAQ:BDMS) shares remains unchanged and was closed at $13.27. BDMS EPS growth in last 5 year was -19.30%. Birner Dental Management Services Inc. (NASDAQ:BDMS) year to date (YTD) performance is -6.94%.
Birner Dental Management Services, Inc. (NASDAQ: BDMS), will conduct a conference call to review nine month and third quarter 2015 results. In addition to nine month and third quarter 2015 results, the teleconference may include discussion of management’s expectations of future financial and operating results. The call will be held on Thursday, November 12, 2015 at 9:00 a.m. MT.
Repros Therapeutics Inc. (NASDAQ:RPRX) shares decreased -9.42% in last trading session and ended the day at $1.73. RPRX has a return on assets of -72.30%. Repros Therapeutics Inc. (NASDAQ:RPRX) quarterly performance is -77.88%.
On 29 October, Repros Therapeutics Inc.(R) (NASDAQ:RPRX) announced that the Division of Bone, Reproductive and Urologic Products of the U.S. Food and Drug Administration (FDA) has cancelled the scheduled November 3, 2015 advisory committee to review the Company’s New Drug Application (NDA) for its enclomiphene product candidate, formerly known as Androxal(R), due to questions that arose late in the review regarding the bioanalytical method validation that could affect interpretability of certain pivotal study data.
Triple-S Management Corporation (NYSE:GTS) caters to the Financial space. It has a net profit margin of 2.60% and weekly performance is 24.42%. On the last day of trading company shares ended up at $25.63. Triple-S Management Corporation (NYSE:GTS) distance from 50-day simple moving average (SMA50) is 26.65%.
Triple-S Management Corporation (NYSE: GTS) announced that Ramón M. Ruiz-Comas, President and Chief Executive Officer, Roberto García-Rodríguez, Chief Operating Officer and Amílcar Jordan, VP and Chief Financial Officer, will present to investors and financial analysts at the 2015 Stifel Healthcare Conference in New York on Tuesday, November 17 at 8:00 a.m. Eastern Time.
Leave a Reply